Membrane permeability and stability of liposomes made from highly fluorinated double-chain phosphocholines derived from diaminopropanol, serine or ethanolamine  by Clary, Laurence et al.
 .Biochimica et Biophysica Acta 1328 1997 55–64
Membrane permeability and stability of liposomes made from highly
fluorinated double-chain phosphocholines derived from
diaminopropanol, serine or ethanolamine
Laurence Clary, Geraldine Verderone, Catherine Santaella, Pierre Vierling )´
Laboratoire de Chimie Bioorganique, UPRESA 6001 CNRS, Faculte des Sciences, Uni˝ersite de Nice–Sophia Antipolis, B.P. 71,´ ´
06108 Nice Cedex 02, France´
Received 30 January 1997; accepted 31 March 1997
Abstract
 .The release of encapsulated carboxyfluorescein CF from liposomes made from various fluorinated amido-connected
double-chain phosphocholines and their membrane permeability have been investigated at 378C in buffer and in human
serum. These fluorinated membranes and liposomes display lower permeability coefficients and are able to retain more
efficiently encapsulated CF than any of their respective conventional counterparts. Several of these liposomes are as
effective as the first generation of liposomes based on fluorinated phosphatidylcholines, indicating that the chemical
 .  .junction esterramide and nature of the unit glycerol, diaminopropanol, serine, ethanolamine connecting the hydrophobic
chains to the phosphocholine polar head have no significant effect on permeability and CF release. Our results show further
that a fluorinated intramembrane layer reduces significantly the permeability of membranes in a liquid-crystalline state,
 .protects the liposomes from the destabilizing effects of serum, and even increases their stability in terms of dye retention
in serum when the membranes are in the gel state. q 1997 Elsevier Science B.V.
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1. Introduction
The therapeutic potential of liposomes as drug
carrier and delivery systems has stimulated numerous
w xstudies over the past decade 1–6 . Protection of the
liposome’s surface by gangliosides or poly oxyethy-
.lene -derivatized lipids with the development of
‘stealth’ liposomes, i.e., liposomes that can escape
premature removal from blood circulation by the
.mononuclear phagocytic system has allowed signifi-
) Corresponding author. Fax: q33 04 92076151.
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cant progress in this field. Despite these improve-
ments, several obstacles still remain that limit their
applications.
We have already shown that highly fluorinated
analogs of natural phosphatidylcholines i.e.,
.DFnCmPC compounds in Fig. 1 form bilayers and
liposomes containing, inside the membrane, a highly
whydrophobic and lipophobic fluorocarbon layer 7–
x10 . Such ‘fluorinated’ membranes and liposomes
display remarkable and original physico-chemical and
biological properties that differ substantially from
those of conventional ones lower membrane perme-
w xability, increased stability in biological media 9,10 ,
w x.extended in vivo blood circulation time 11 . As for
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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Fig. 1. Chemical structure and code name of the various fluoro-
carbon amido-connected phosphocholines together with those of
their ester-connected glycerophosphocholine analogs used as ref-
erences in this study.
membrane permeability, drug encapsulation and re-
lease, which are key issues when the use of lipo-
somes as drug delivery systems is concerned, the
intramembrane fluorocarbon film constitutes an effi-
cient barrier against the release of entrapped water
 .soluble compounds such as carboxyfluorescein , even
when the liposomes are incubated in human serum
w x9 . Moreover, active loading of doxorubicin into
fluorinated liposomes can also be achieved efficiently
w x10 .
With the aim of extending the potential of fluori-
nated liposomes as drug carrier and delivery devices,
we have developed new highly fluorinated amido-
w x connected phospholipids 12 compounds I to IV,
.Fig. 1 . The modular design of their molecular struc-
ture is expected to modulate the physico-chemical
and biological properties including permeability, sta-
bility in biological fluids, interactions with biocom-
.pounds, in vivo fate of the fluorinated membranes
and liposomes they form. This design involves two
 . long hydrophobic chains, one IIIa or both I, II,
.IIIb–d and IV of which end in a highly fluorinated
tail, connected through amide bonds to 2,3- or 1,3-di-
 .  .aminopropano- I, II , serino- III or aminoethyl-
 .phosphocholine IV polar head groups. The amide
bonds are intended to confer higher chemical and
biological stability in acidic media and more particu-
.larly towards the action of phospholipases to these
w xfluorinated phospholipids and to their liposomes 13 .
Furthermore, the CONH amide linkage provides an
important inter- and intra-molecular hydrogen bond
w xcapability 14,15 . The formation of a hydrogen bond
network within the membrane in proximity to the
water interface is expected to enhance the physical
and biological stability of the membrane and, conse-
quently, to increase the in vivo blood circulation
times of the liposomes formed from these ami-
dophospholipids, as found for liposomes formulated
w xwith sphingomyelins 16 , which are naturally occur-
ring amidophospholipids.
We have already reported that the new fluorinated
amidophospholipids shown in Fig. 1 form long-term
shelf stable liposomes in terms of particle size and
. w xsize distribution 17 and display a rather high in
w xvivo tolerance 12 which are prerequisites when their
use as in vivo drug delivery devices is contemplated.
We report now our detailed investigations on the
ability of their liposomes to retain a passively en-
 .  .trapped drug model, 5 6 -carboxyfluorescein CF
w x18 , when these liposomes are incubated in a physio-
logical buffer or in human serum at 378C. The experi-
mental data obtained are compared to those reported
for the first generation of fluorinated liposomes made
from fluorinated ester-connected phosphatidyl-
 . w xcholines i.e., DFnCmPC compounds in Fig. 1 9
and for conventional liposomes made from hydrocar-
bon phosphatidylcholines alone or in combination
 .with cholesterol CH . The effects of the fluorocar-
bon lipophobic intramembrane layer and of the
molecular structure of the fluorinated phospholipids
on CF release and on membrane permeability are also
discussed.
2. Materials and methods
The syntheses of the various fluorinated amido-
 .connected phosphocholines Fig. 1 used here are
w x  .described in Ref. 12 . Their purity )99% was
periodically checked by TLC, 1H- and 31P-NMR.
 .  .  .5 6 -carboxyfluorescein CF , cholesterol CH; 99%
and sodium deoxycholate were purchased from Sigma
and used as received. rac-1,2-Distearoylphosphati-
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 .dylcholine DSPC came from FLUKA and its purity
 .)99% was controlled by TLC before use. The egg
 .phosphatidylcholines EPC Lipoid E-100, from
 .Lipoid KG Ludwigshafen, Germany , contain phos-
phatidylcholines and lysophosphatidylcholines
 .98.0% wrw with lysophospholipids -3.0% . Hu-
man serum was provided by the ‘Centre Departemen-´
tal de la Transfusion Sanguine des Alpes-Maritimes’
and was a pool from several donors.
2.1. Preparation of unilamellar liposomes
 .Typically, the phospholipids 25 mM were hy-
drated for 30–45 min in a 100 mM CF solution 0.5
.ml; pH 7.5 at 10 to 158C above their gel to liquid-
crystalline phase transition temperatures T listed inc
Table 1. These suspensions were then sonicated using
a 3 mm titanium probe Branson Sonic Power Co.
.Sonifier Cell Disrupter B300 , at a temperature above
T , until they became clear and translucent, or ex-c
truded through a polycarbonate membrane Lipo-
.sofast Milsch Equipment; size filter 100 nm . The
liposomes made from DSPCrCH or EPCrCH 1:1,
.mol ratio were prepared starting from a dried film
obtained by evaporating a chloroformrmethanol so-
lution of the two lipids. These films were hydrated
and the suspensions sonicated at 70 and 408C, respec-
tively. All vesicle suspensions were then aged above
the T of the phospholipids for 12 h prior to releasec
measurements. The DSPCrCH and EPCrCH vesi-
cles were aged at 60 and 408C, respectively. Un-en-
capsulated CF was removed by gel-filtration through
a Sephadex G-50 mini-column equilibrated with a 20
mM Hepes buffer pH 7.5 containing 0.1 M Na SO2 4
or 0.15 M NaCl. These separations were performed at
room temperature just before the release experiments
were run. The average vesicle diameter was then
measured by photon correlation spectroscopy using a
Coulter N4 MD submicron particle size analyzer.
2.2. CF release experiments in buffer or in human
serum
The release experiments were run immediately
after the separation of the un-encapsulated dye from
w xthe liposomes, as described in Ref. 9 . In a typical
dye-release assay, the liposome suspension 5 to 15
. ml or 30 to 50 ml was mixed with 2 ml of buffer 20
mM Hepes buffer pH 7.5 containing either 0.15 M
.NaCl or 0.1 M Na SO or of human serum, and2 4
incubated at 378C in a thermoregulated quartz cuvette
 .cell 1 cm with magnetic stirring. The release of the
entrapped probe from the liposomes which increases
the fluorescence of the dye because of its dilution-de-
.pendent dequenching was followed by continuous
monitoring of the fluorescence increase, F, excita-
.tion at 480 nm and emission at 520 nm on a Perkin
Elmer Spectrofluorometer LS 50B. The fluorescence
signal, F , corresponding to 100% of CF release,max
was determined after lysis of the liposomes with a
 .10% sodium deoxycholate 20 ml solution. In hu-
man serum, owing to serum–detergent interaction
w x19 , F was determined in a separate experimentmax
by adding, to 2 ml of human serum, the same aliquot
of liposomes which have been disrupted with a 10%
sodium deoxycholate solution. In the range of dye
concentration used, the relation between fluorescence
and dye concentration was linear both in the buffer
and in human serum. F and F were corrected formax
dilution effects and diffusion background. Each ex-
periment was performed at least in triplicate.
The CF leakage half-time t time at which 50%1r2
.of CF is still encapsulated was determined by plot-
w ting the fraction, R, of encapsulated dye Rs Fmax
. x   ..yF rF vs. time or calculated t s ln 2rKmax 1r2
from the slope K of the linear portion of the curve of
ln R vs. time corresponding to the late phase of
release. The profiles of CF release from the vesicles
incubated in buffer were in most cases mono-ex-
ponentional. In some cases, the kinetics were bipha-
sic with an initial phase of fast release mainly related
to the temperature increase the separation of un-en-
trapped CF from the vesicles was indeed performed
at room temperature before the release experiments
.were run at 378C . The time-courses of CF release
from the vesicles which had been incubated in human
serum were recorded over 2-h and 24-h periods. The
kinetics were then multiphasic, with an initial phase
of fast release and a late phase of slower release,
indicating that, in human serum, the slowest release
phase is obtained for higher periods of incubation.
Assuming that the CF release occurs via a classical
diffusion mechanism, the permeability coefficients,
P, were calculated from the time-course of CF re-
lease from the vesicles incubated in the buffer using
Fick’s law. P is related to the slope K by Ps
 .rr3 K , where r is the internal radius of the vesicle.
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The latter is related to the external diameter d mea-
.sured by photon correlation spectroscopy by rs
 .dr2 yDx, with Dx estimated to be 3.6 nm for the
membranes in the liquid-crystalline state and 4.8 nm
w x  w x.in the gel state 20–22 for more details see Ref. 9 .
3. Results
The leakage half-time values, t , and the perme-1r2
ability coefficients of CF, P, determined or calcu-
lated from the time-course of CF release curves not
.shown from unilamellar vesicles made of the various
fluorinated phospholipids displayed in Fig. 1 and
incubated at 378C in a buffer or in human serum, are
 .listed in Table 1. This table collects also i the
serumrbuffer t ratio values which express the1r2
 .serum effects on CF release and ii the same parame-
ters for selected fluorinated liposomes made from
 .DFnCmPC phosphatidylcholines Fig. 1 , and for
conventional liposomes made from hydrocarbon
phosphatidylcholines used either alone or in combina-
tion with cholesterol.
The diagrams in Fig. 2 A and B illustrate the
evolution of the t values for liposomes incubated1r2
 .in a HepesrNaCl 20 mMr0.15 M buffer or in
human serum and for which the membranes are in the
 .  .liquid-crystalline Fig. 2A or gel state Fig. 2B . Fig.
3 shows the dependence of the permeability coeffi-
cients P of CF across the various liposomal mem-
branes on the hydrophobic chain length L L repre-
sents the number of carbon atoms constituting one
.chain or the mean when both chains are different .
These diagrams allow a more convenient comparison
between the different liposomal formulations and
membranes.
3.1. CF release from liposomes and permeability of
membranes in the liquid-crystalline state
In a Na SO or NaCl buffer and at 378C, the t2 4 1r2
values of CF leakage from the fluorinated amido-
based liposomes whose membranes are in the liquid-
crystalline state, are in the 11–60 h range, while that
of the ‘liquid-crystalline’ hydrocarbon rac-1,2-di-
 .myristoylphosphatidylcholine DMPC is of 0.4 h
 .Table 1 . In addition, the P coefficients for the
‘liquid-crystalline’ fluorinated membranes Table 1
.and Fig. 3 are all significantly much lower than that
 .Fig. 2. Comparison of the carboxyfluorescein CF release from
conventional or fluorinated unilamellar liposomes when incu-
 .bated in a buffer hatched bars or in human serum at 378C. The
 .liposomal membrane is, at 378C, A in the liquid-crystalline
 .state, B in the gel state.
calculated for DMPC, some being even lower than
that of ‘gel’ rac-1,2-dipalmitoylphosphatidylcholine
 .DPPC membranes. These results indicate that the
‘liquid-crystalline’ fluorinated liposomes retain their
content much more efficiently and display a signifi-
cantly lower membrane permeability than their
‘liquid-crystalline’ conventional DMPC analogs. This
is already the case for the mixed-chain
w xw xhydrocarbonrfluorocarbon C16 F6C11 SerPC phos-
pholipid which forms liposomes and membranes that
are even less leaky and less permeable than those
made from double-chain fluorocarbonrfluorocarbon
 .analogs Table 1 .
One can further notice that some of the fluorinated
‘liquid-crystalline’ liposomes and membranes e.g.,
w xw x w xw x .F4C11 F6C11 SerPC or C16 F6C11 SerPC dis-
 .play CF release rates and P coefficients Table 1
which are, respectively, comparable to those of the
 .fluorinated ‘gel’ ones see Section 3.2 . Indeed, the
t and P values corresponding to these liposomes1r2
and membranes lie in similar range values 45–85 h
 . y12 .and 3.2–17.6 =10 cmrs, respectively . This
differs considerably from what is found for the con-
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Fig. 3. Variation of the permeability coefficients, P, for fluori-
nated and conventional unilamellar liposomes with the length L
 w Xof the phospholipid’s hydrophobic chains Ls nq m or nq n
X x  X.q mq m r2 when both chains are of different length; n n s
 X.number of carbon atoms of the fluorinated tail; m m snumber
.of carbon atoms of the hydrocarbon spacer or chain, see Fig. 1 .
The symbol ) indicates that the P value is corresponding to
liposomal membranes which are close to their phase transition
 .DPPC or in the gel state. When not indicated, error bars are
smaller than the signs. P is calculated from the time-course of
CF release from the vesicles incubated in the Na SO buffer see2 4
.Section 2 .
ventional liposomes and membranes for which the
impact of the physical state on t and P is much1r2
more important: thus, t increases from 0.6 h for1r2
liquid-crystalline DMPC to 9 and 14 h for gel DPPC
or DSPC, and, concomitantly, P decreases from 464
y12  . y12=10 cmrs for DMPC to 37 or 9 =10 cmrs
 .for DPPC or DSPC, respectively see Fig. 3 . These
results most likely indicate that the fluorocarbon in-
tramembrane layer acts as an efficient barrier to
permeation when the membrane is in a liquid-crystal-
line state.
When incubated in human serum, the CF release
from the fluorinated amido-based liposomes t in1r2
.the 0.4 to 54 h range is also much slower than from
 .conventional DMPC ones t -0.017 h , indicating1r2
a greater stability of the former formulations Table
.1, Fig. 2A . However, as shown by the serumrbuffer
 .t ratios Table 1 which, in most cases, are far1r2
below 1, serum destabilizes most of these ‘liquid-
crystalline’ fluorinated liposomes as it is also the case
for the ‘liquid-crystalline’ conventional DMPC ones.
w xw xBy contrast, the F4C11 F6C11 SerPC liposomes are
almost unaffected by the serum components t1r2
.ratio close to 1 . Among the fluorinated formulations,
the liposomes made from the mixed-chain fluorocar-
w xw xbonrhydrocarbon C16 F6C11 SerPC phospholipid,
e.g., the less fluorinated one of the series investigated
 .Fig. 1 , appear to be most destabilized.
Fluorinated liposomes made from phospholipids
 .possessing the same hydrophobic chains e.g. F4C11
belonging either to the amide series deriving from
 . serine DF4C11SerPC , diaminopropanol 1,3-
.  .DF4C11APC or aminoethanol DF4C11AEPC , or
to the ester series deriving from glycerol
 .DF4C11PC , display comparable CF release rates
and permeability coefficients when incubated in a
 .buffer Table 1, Fig. 2A and Fig. 3 . However, this is
no more the case when the liposomes are incubated
in human serum: all the amide-based formulations are
much more leaky than the vesicles made from the
ester DF4C11PC. These results indicate that the
 .chemical nature of the junction amide, ester andror
the connecting group serine, diaminopropanol,
.aminoethanol, glycerol between the hydrophobic
chains and the PC polar head has almost no effect on
membrane permeability to CF but does have a signif-
icant contribution on CF release when the liposomes
are placed in the presence of serum components.
3.2. CF release from liposomes and permeability of
membranes in the gel phase
When incubated in a buffer, the ‘gel’ fluorinated
amido-based liposomes display t values which are1r2
higher than those of the conventional ‘gel’ DSPC
ones and comparable to those of CH-containing ones
 .Table 1, Fig. 2B . However, both types of mem-
  .branes exhibit similar P values ranges 6.5–12.9 =
y12  . y1210 cmrs and 4–9 =10 cmrs, respectively;
.Table 1, Fig. 3 , indicating that in the gel state no
significant difference in permeability exists between
fluorocarbon and conventional membranes.
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As for the ‘liquid-crystalline’ formulations, it was
also found that the ‘gel’ amido-based 2,3- or 1,3-
.DF6C11APC or DF6C11SerPC and ‘gel’ DF6C11PC
ester-based liposomes exhibit comparable CF release
 .rates and P coefficients Table 1 and Fig. 3 , indicat-
ing that the chemical nature of the connecting group
 .diaminopropanol, serine or glycerol has almost no
influence on membrane permeability.
When incubated in human serum, all ‘gel’ fluori-
nated amido-based liposomes display very high t1r2
values which are larger than those of DSPC or of
EPCrCH liposomes. The 1,3-DF6C11APC and
DF6C11SerPC liposomes display CF release rates
similar to those of the fluorinated ester-based
DF6C11PC or of conventional DSPCrCH ones Ta-
.ble 1 and Fig. 2B . It should be noticed that the ‘gel’
1,3-DF6C11APC, DF6C11SerPC or DF6C11PC lipo-
somes and the conventional ‘gel’ DSPCrCH ones are
much more stable when incubated in human serum
rather than in buffer, as shown by the large
 .serumrbuffer t values )10; Table 1 . This is1r2
also the case for ‘gel-like’ EPCrCH ones, but to a
 .lesser extent t ratio of 4 . On the other hand, the1r2
‘gel’ conventional DSPC vesicles are almost not per-
turbed by the human serum components t ratio of1r2
.1 . These results indicate that the presence of a
fluorocarbon film within a membrane improves the
stability of the liposomes, in terms of dye retention,
in a similar way to that resulting from the addition of
cholesterol to DSPC or EPC membranes.
As far as the impact of the 2,3- or 1,3-isomerism is
concerned, both 2,3- and 1,3-DF6C11APC form lipo-
somes that efficiently retain encapsulated CF and
possess comparable P coefficients when incubated in
 .buffer Table 1 . However, when incubated in human
serum, liposomes formed from the 1,3-isomer are
 .significantly more stable 4-fold than those from
isomer 2,3.
4. Discussion
The main objective of this study was to determine
the potential of liposomes made from highly fluori-
 .nated amidophosphocholines Fig. 1 as alternative
drug carrier and delivery systems, comparatively to
that of liposomes formed from fluorinated such as
.DFnCmPC in Fig. 1 or conventional phosphatidyl-
w xcholines 9,10 . In order to further evaluate the im-
pact of the modular structure of the fluorinated phos-
pholipids amide vs. ester bond, serine, diamino-
propanol or ethanolamine vs. glycerol connecting
.backbone and to gain some additional structurerper-
 .meabilityrstability with respect to drug release rela-
tionships, we have therefore investigated and com-
pared the ability of the various new fluorinated vesi-
 .cles to retain encapsulated carboxyfluorescein CF .
These liposomes were incubated at 378C in a buffer
and in human serum which, among the biological
fluids, is known to have most pronounced effects on
w xmembrane permeability and liposome stability 23 .
Our following discussion takes also into account that,
at the incubation temperature, the liposomal mem-
branes are either in the gel or liquid-crystalline state
which is well-known to influence membrane perme-
w x.ability 4,24 .
4.1. Liposome stability in a buffer and membrane
permeability
Our results clearly demonstrate that the presence
of a fluorinated core within the liposomal membrane
in the liquid-crystalline state constitutes a very effi-
cient barrier for the permeation of the hydrophilic
CF. Indeed and regardless of the number of fluoro-
carbon chains and length of both the hydrophobic
chains and fluorinated tails, the vesicles made from
the fluorinated amidophospholipids e.g., 1,3-
DF4C11APC, DF4C11AEPC, DF4C11SerPC,
w xw x w xw x .F4C11 F6C11 SerPC or C16 F6C11 SerPC , when
incubated in a buffer at 378C, retain entrapped CF
much more efficiently and exhibit much lower mem-
brane permeability than the ‘liquid-crystalline’ con-
ventional DMPC counterparts Table 1 and Figs. 2
.and 3 . The remarkable efficiency of the fluorinated
core to reduce membrane permeability and drug re-
lease is best illustrated by the characteristics of the
membranes and liposomes of the mixed hydrocar-
w xw xbonrfluorocarbon double-chain C16 F6C11 SerPC
which is the less fluorinated among the fluorinated
phospholipids investigated here. It is indeed notewor-
w xw xthy that the C16 F6C11 SerPC-based membrane dis-
 .plays a P coefficient which is i not only much
lower than that of the DMPC-based membrane, but
 .also comparable ii to that of the ‘liquid-crystalline’
flu o ro ca rb o n r flu o ro ca rb o n d o u b le -ch a in
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w xw xF4C11 F6C11 SerPC-based one and, even more re-
 .markable, iii to that of the ‘gel’ fluorocarbonrfluo-
rocarbon double-chain DF6C11SerPC one. Similar
results have been evidenced for mixed double-chain
fluorocarbonrhydrocarbon glycerophosphocholines
as compared to homogeneous fluorocarbon double-
w xchain ones 25 .
However, for membranes in the gel state, the
fluorinated intramembrane film has almost no effect
on CF permeation: both the ‘gel’ fluorinated ami-
dophosphocholine-based and conventional DSPC-
based membranes display indeed comparable perme-
 .ability P coefficients Table 1 and Fig. 3 . This result
is also in line with our previous studies concerning
‘gel’ fluorinated membranes and liposomes made
w xfrom fluorinated diacyl DFnCmPC 9 or dialkyl
w xglycerophosphocholines 25 .
The effects on membrane permeability arising from
the presence of a fluorinated intramembrane film can
be attributed to its high hydrophobic and lipophobic
 .character. Such a character is expected to reduce i
 .the probe’s solubility or its penetration in the hy-
drophobic phase of fluorinated membranes the much
lower solubility of hydrophilic and lipophilic com-
pounds in fluorinated membranes has indeed been
w x.  .established 8 , andror ii its diffusion more partic-
ularly across a fluorinated layer. Both these factors,
along with others, control permeation of a dye across
 .a membrane. This analysis accounts for i the higher
efficiency of any of the fluorinated ‘liquid-crystal-
line’ liposomes to retain CF as compared to the
 .conventional ‘liquid-crystalline’ DMPC ones, ii the
very low impact of the fluorinated intramembrane
layer on CF release in the case of ‘gel’ fluorinated
 .membranes and iii the small gaps in CF release
rates and permeability P coefficients between
‘liquid-crystalline’ and ‘gel’ fluorinated liposomes
while the differences are much more important for
the conventional ones. The surprising larger or simi-
lar membrane permeability and dye release ability of
‘gel’ fluorinated liposomes as compared to some
‘ liquid-crystalline’ fluorinated ones e.g.,
w xw x w xw x .F4C11 F6C11 SerPC or C16 F6C11 SerPC could
also arise from the presence of packing defects which
are more important for ‘gel’ membranes and also for
membranes whose phase transitions are large and
occur over a temperature range including the incuba-
tion temperature which is the case for the fluorinated
w x.‘gel’ membranes 17 , thus facilitating transmem-
brane diffusion.
4.2. Liposome stability in human serum
Serum is among the biological fluids known to
induce strong destabilizing effects on membranes in
w xtheir liquid-crystalline state 23 . Most of the new
fluorinated herein investigated liposomes, whose
membranes are in the liquid-crystalline state at 378C,
are also destabilized by the serum components but to
a considerably lesser extent than the ‘liquid-crystal-
line’ DMPC conventional ones Table 1 and Fig.
.2A . On the other hand, the fluorinated core improves
dye retention for the fluorinated liposomes in serum,
 .when their membranes are in the gel state Fig. 2B .
Indeed, the ‘gel’ fluorinated liposomes display not
only a significantly greater stability in serum than in
buffer, but they are noticeably even more stabilized
in serum than conventional ‘gel’ DSPC liposomes. A
similar behavior was found for conventional DSPC or
EPC membranes but only upon addition of choles-
w x 1terol to these membranes 16 .
These results are very similar to those already
found for ‘liquid-crystalline’ or ‘gel’ liposomes for-
mulated with fluorinated glycerophosphocholine
w xanalogs 9,25 . They further indicate that the fluori-
nated intramembrane core with its lipophobicrhydro-
phobic characteristics definitely protects the vesicles,
possibly by reducing their interactions with the
lipophilic andror hydrophilic serum components lim-
iting their adsorption at the surface andror hindering
their penetration deeper into the fluorinated bilayer.
As the stability of liposomes in serum involves the
interaction of serum proteins usually negatively
. w xcharged with the bilayer 26 , the extended stability
of the fluorinated liposomes in serum may also stem
from the large negative dipole potential of fluorinated
membranes while that of conventional ones is posi-
. w xtive 22 . This has been shown to modify substan-
tially the binding of negatively charged
w xlipophilicrhydrophobic ions 22 , thus strongly sup-
porting a reduction of the binding of the negatively
1 In the absence of cholesterol, EPC liposomes are, at 378C,
 .much more leaky in human serum t of CF release is 0.12 h1r2
 . w xthan in buffer t s13 h 8 .1r2
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charged serum proteins that partition into the interfa-
cial region of the bilayer. In addition, the greater
stability of the ‘gel’ fluorinated vesicles in serum
than in buffer could indicate that some serum con-
stituents participate in increasing the order or packing
of the phospholipids within the membrane, andror in
suppressing packing defects which frequently arise
for liposomes with membranes in the gel state.
4.3. StructurerpermeabilityrCF release
relationships
Another objective of this study was to compare the
potential of the liposomes formulated with these new
fluorinated double-chain amidophosphocholines to
that reported for the first generation of fluorinated
ester phosphatidylcholine-based liposomes, hence to
evaluate the impact of the esterramide bond or of the
connecting backbone ethanolamine, diamino-
.propanol, serine vs. glycerol on permeability to CF
and release. We found that these structural variations
have in most cases almost no effect: indeed, mem-
branes and liposomes prepared either from the
amido-connected DF4C11AEPC, 1,3-DF4C11APC,
DF4C11SerPC, DF6C11APC or DF6C11SerPC or
from their DF4C11PC or DF6C11PC ester homologs,
respectively, behave very similarly in terms of per-
meability and CF release. Significant differences of
behavior in human serum are only observed between
w xw xthe ‘liquid-crystalline’ F4C11 F6C11 SerPC or
DF4C11PC liposomes and the other ‘liquid-crystal-
line’ fluorinated amido-based formulations. However,
the two former formulations seem to constitute ex-
ceptions since several ‘liquid-crystalline’ fluorinated
formulations made from other fluorinated phos-
phatidylcholines were found to be less stable in hu-
w xman serum than in buffer 9 .
The differences in permeability and CF release
rates observed for the 2,3- and 1,3-DF6C11APC
isomer-based liposomes, when incubated in human
serum, are most likely related to phase behavior
rather than to membrane permeability properties. In-
deed, we have shown elsewhere that 2,3-
DF6C11APC, when dispersed in an aqueous phase,
forms a metastable lamellar phase which slowly con-
w xverts into a ribbon-like phase 17 . This phase transi-
tion may be accelarated by the serum components,
thus increasing CF release.
5. Conclusion
We have shown that membranes and liposomes
whether formulated with double-chain fluorocarbonr
fluorocarbon or mixed fluorocarbonrhydrocarbon
amido-based phosphocholines are able to retain effi-
ciently encapsulated CF, even when incubated in
human serum. These liposomes are as stable, with
respect to CF release, as the first generation of lipo-
somes formulated with the fluorinated phosphatidyl-
w xcholines 9 . These results are most important as these
new compounds bring an easy access to drug carrier
system components, together with improved chemical
and biochemical stability. They further confirm that a
fluorinated intramembrane layer reduces the perme-
ability of membranes more significantly when they
.are in a liquid-crystalline state , protects them from
the destabilizing effects of serum and increases even
 .the stability in terms of dye retention of the fluori-
nated liposomes whose membranes are in the gel
state, when incubated in serum. This effect is similar
to that resulting from the addition of cholesterol to
conventional membranes.
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